Anti-LILRA1 antibodies are used in the immunodetection of the protein leukocyte immunoglobulin like receptor A1. In humans, the canonical protein has a reported length of 489 amino acid residues and a mass of 53.3 kDa. Its subcellular localization is in the membrane. Up to 2 different isoforms have been reported for this protein. It is notably expressed in monocytes and B-cells. LILRA1 is believed to act as receptor for class I MHC antigens. Post-translational modifications have been described, including glycosylation. Synonyms for this target antigen include LIR-6, LIR6, leukocyte immunoglobulin-like receptor subfamily A member 1, CD85 antigen-like family member I, and CD85I. LILRA1 gene orthologs have been reported in the mouse and rat species. A number of LILRA1 antibodies have been mentioned in research publications and have associated citations. Western Blot is a widely used application for these antibodies. ELISA and Immunofluorescence are also common applications.